原創(chuàng)論文益生菌耐藥性研究進(jìn)展-在線瀏覽
2025-03-05 10:57本頁(yè)面
【正文】 , 張曉東等. 益生菌的功效及遺傳修飾. 生物信息學(xué)，2006，4: 186189.[3] 陳有容, 鄭小平. 益生菌的健康功效及其應(yīng)用[J]. 上海水產(chǎn)大學(xué)學(xué)報(bào)，2001，10(3): 269—275．[4] . HamiltonMiller, . Deficiencies in microbioiogical quality and labeling of probiotic supplements. International Journal of Food Microbiology. 2002, 27(12): l75.[5] T. Mattila, Sandholm, P. Myllarinen, R. Crittenden, et al. Technological challenges for future probiotic foods, International Dairy Journa1. 2002, 12(23): 173182.[6] Taksno T. Milk derived peptides and hypertension reduction[J]. Infl DairyJ, 1998, 8: 375381.[7] . 藥學(xué)進(jìn)展, 2008，18（4）：36.[8] Lzumi S, Aranishi F. Relationship between gyrA mutations and quinolone resistance in Flavobacterium psychrophilum isolates. Appl Environ Microbiol, 2004, 70(7): 39683972.[9] Macinga DR, Renick PJ, Makin KM, et al. Unique biological properties and molecular mechanism of 5, 6bridged quinolones. Antimicrob Agents Chemother, 2003, 47(8): 25262537.[10] Tran JH, Jacoby GA. Mechanism of plasmidmediated quinolone resistance. Proc Natl Acid Sci USA, 2002, 99(8): 56385642.[11] Davies J, Smith D1. Plasmiddetermined resistance to antimicrobial agents[J]. Annd Rev Microbiol, 1978, 32: 469518.[12] Dorthe S, Frank MA, Lars BJ. Charactefisation of integrons and an tibiotic resistance genes in Dan ish multiresistants Salmonella enterica Typhirnuriurn DT104[J]. FEMS Microbiology Letter 1998, 160: 3741.[13] Mobak KDL, Baggesen FK, Aarestrup JM, et a1. An outbreak of multidrugresistant, quinoloneresistant Salmonella enterica sero type Typhimuriurn DT104[N]. Ensl Med, 1999, 341: 14201425.[14] Corpet DE, Lumeau S, Corpet F. Mimimum antibiotic levels for selecting a resistance plasmid in a gnotobiotec animal model[J]. Antimicrobial Agent
環(huán)評(píng)公示相關(guān)推薦
鄂ICP備17016276號(hào)-1